• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Variation in normal tissue responsiveness to WR-2721.

作者信息

Yuhas J M, Afzal S M, Afzal V

出版信息

Int J Radiat Oncol Biol Phys. 1984 Sep;10(9):1537-9. doi: 10.1016/0360-3016(84)90498-x.

DOI:10.1016/0360-3016(84)90498-x
PMID:6090357
Abstract

The radioprotection afforded normal tissues by WR-2721 or S-2-[3-aminopropylamino]ethylphosphorothioic acid varies widely, with some of the most responsive tissues showing low levels of absorbed drug and vice versa. While the oxygen tension of the respective tissues may be contributing to this variation, it can be shown that the drug is not homogeneously distributed within each tissue, and that its location within the sub-cellular compartments can vary widely. Recognition of this variability, when combined with the newly developed HPLC assays for drug quality, should provide new insights into the sources of variation in normal tissue responsiveness to these agents.

摘要

相似文献

1
Variation in normal tissue responsiveness to WR-2721.
Int J Radiat Oncol Biol Phys. 1984 Sep;10(9):1537-9. doi: 10.1016/0360-3016(84)90498-x.
2
Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acid.以主动与被动吸收动力学为基础,研究S-2-(3-氨丙基氨基)乙硫代磷酸对正常组织的选择性保护作用。
Cancer Res. 1980 May;40(5):1519-24.
3
In vitro metabolism of the phosphorothioate radioprotectors WR-2721 and WR-3689.
Pharmacol Ther. 1988;39(1-3):215-7. doi: 10.1016/0163-7258(88)90064-2.
4
Human pharmacokinetics of WR-2721.WR-2721的人体药代动力学。
Int J Radiat Oncol Biol Phys. 1986 Aug;12(8):1501-4. doi: 10.1016/0360-3016(86)90203-8.
5
Distribution of 35S-labeled WR-2721 in normal and malignant tissues of the mouse1,2.35S标记的WR-2721在小鼠正常组织和恶性组织中的分布1,2 。
Radiat Res. 1976 Nov;68(2):284-91.
6
Pharmacokinetics of WR-1065 in mouse tissue following treatment with WR-2721.
Int J Radiat Oncol Biol Phys. 1984 Sep;10(9):1525-8. doi: 10.1016/0360-3016(84)90495-4.
7
Alkaline phosphatase promotes radioprotection and accumulation of WR-1065 in V79-171 cells incubated in medium containing WR-2721.碱性磷酸酶可促进在含有WR-2721的培养基中孵育的V79-171细胞对辐射的防护作用以及WR-1065的积累。
Int J Radiat Biol Relat Stud Phys Chem Med. 1985 Jan;47(1):23-7. doi: 10.1080/09553008514550041.
8
Synthesis, biodistribution, and autoradiography of radiolabeled S-2-(3-methylaminopropylamino)ethylphosphorothioic acid (WR-3689).放射性标记的S-2-(3-甲基氨基丙基氨基)乙硫代磷酸(WR-3689)的合成、生物分布及放射自显影
Radiat Res. 1986 Jun;106(3):366-79.
9
[Studies on the radioprotective effects of YM-08310 (= WR-2721) Part 1: Radioprotective effects of YM-08310 on normal and malignant tissues in mice].[YM-08310(=WR-2721)的辐射防护作用研究 第1部分:YM-08310对小鼠正常组织和恶性组织的辐射防护作用]
Nihon Igaku Hoshasen Gakkai Zasshi. 1983 May 25;43(5):700-9.
10
The role of WR-2721 in radiotherapy and/or chemotherapy.WR-2721在放疗和/或化疗中的作用。
Cancer Clin Trials. 1980 Fall;3(3):211-6.

引用本文的文献

1
Cancer Incidence in C3H Mice Protected from Lethal Total-Body Radiation after Amifostine.氨磷汀保护下的 C3H 小鼠的辐射致癌性
Radiat Res. 2018 May;189(5):490-496. doi: 10.1667/RR14987.1. Epub 2018 Mar 12.
2
Normal tissue protection for improving radiotherapy: Where are the Gaps?改善放射治疗的正常组织保护:差距在哪里?
Transl Cancer Res. 2012 Jun;1(1):35-48.
3
Zebrafish as a model system to screen radiation modifiers.斑马鱼作为筛选辐射调节剂的模型系统。
Curr Genomics. 2007 Sep;8(6):360-9. doi: 10.2174/138920207783406497.
4
Antioxidants reduce consequences of radiation exposure.抗氧化剂可减轻辐射暴露的后果。
Adv Exp Med Biol. 2008;614:165-78. doi: 10.1007/978-0-387-74911-2_20.
5
Amifostine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as a radioprotector and cytotoxic chemoprotector.氨磷汀。对其药效学和药代动力学特性以及作为辐射防护剂和细胞毒性化学保护剂的治疗潜力的综述。
Drugs. 1995 Dec;50(6):1001-31. doi: 10.2165/00003495-199550060-00008.